Skip Navigation


European Heart Journal Advance Access originally published online on June 7, 2005
European Heart Journal 2005 26(16):1666-1675; doi:10.1093/eurheartj/ehi341
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/16/1666    most recent
ehi341v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bauce, B.
Right arrow Articles by Nava, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauce, B.
Right arrow Articles by Nava, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations

Barbara Bauce1, Cristina Basso2, Alessandra Rampazzo3, Giorgia Beffagna3, Luciano Daliento1, Gianfranco Frigo1, Sandro Malacrida3, Luca Settimo4, GianAntonio Danieli3, Gaetano Thiene2,* and Andrea Nava1

1Division of Cardiology, University of Padua Medical School, Padova, Italy
2Institute of Pathology, University of Padua Medical School, Padova, Italy
3Department of Biology, University of Padua, Padova, Italy
4Department of Biochemistry and Pharmacy, Abo Akademi University, Turku, Finland

Received 3 November 2004; revised 22 April 2005; accepted 28 April 2005; online publish-ahead-of-print 7 June 2005.

* Corresponding author. Tel: +39 049 8272283; fax: +39 049 8272284. E-mail address: cardpath{at}unipd.it

See page 1582 for the editorial comment on this article (doi:10.1093/eurheartj/ehi343)

Aims To characterize the clinical profile of patients belonging to families affected with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) due to mutations of the gene encoding for the cell-to-cell adhesion protein desmoplakin (DSP).

Methods and results Thirty-eight subjects belonging to four families showing different DSP mutations (three missense and one in the intron–exon splicing region) underwent clinical and genetic investigation, including annual 12-lead ECG, signal averaged ECG, 24 h Holter ECG, and two-dimensional echocardiography. Twenty-six family members (11 males and 15 females) were found to carry a DSP mutation. After a follow-up of 1–24 years, median 6, 14 (54%) fulfilled (mean age at diagnosis 33±15 years) and 12 (mean age 43±24 years at the last follow-up) did not fulfil the established diagnostic criteria of ARVC, although five of them had some cardiac abnormalities. Clinical presentations were palpitations in six, sudden death (SD) in three, syncope in one, and chest pain with increased myocardial enzymes in two. Abnormal 12-lead ECG findings were present in 15 cases (58%), ventricular arrhythmias in 12 (46%), and late potentials in 11 (42%). Fourteen (54%) had abnormal echocardiographic findings, with left ventricular involvement in seven of them. SD occurred in six subjects and in three it was the first symptom of the disease; moreover, one subject died due to heart failure. The annual disease-related death and SD/aborted SD were 0.028 and 0.023 patient/year, respectively.

Conclusion Familial ARVC caused by DSP mutations is characterized by a high occurrence of SD even as first clinical manifestation. Left ventricular involvement is not a rare feature of the disease, which frequently escapes clinical diagnosis by applying the currently available criteria. Genetic screening is mandatory for early identification of asymptomatic carriers and preventive strategies within a family with a genotyped index case.

Key Words: Arrhythmia • Cardiomyopathy • Genetics • Pathology • Sudden death


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype–phenotype studies
Srijita Sen-Chowdhry, Petros Syrris, and William J. McKenna
EHJ 2005 26: 1582-1584. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
Z. A. Bhuiyan, J. D.H. Jongbloed, J. van der Smagt, P. M. Lombardi, A. C.P. Wiesfeld, M. Nelen, M. Schouten, R. Jongbloed, M. G.P.J. Cox, M. van Wolferen, et al.
Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study
Circ Cardiovasc Genet, October 1, 2009; 2(5): 418 - 427.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Jain, D. Dalal, A. Daly, C. Tichnell, C. James, A. Evenson, R. Jain, T. Abraham, B. Y. Tan, H. Tandri, et al.
Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia
Circulation, August 11, 2009; 120(6): 477 - 487.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Pilichou, C. A. Remme, C. Basso, M. E. Campian, S. Rizzo, P. Barnett, B. P. Scicluna, B. Bauce, M. J.B. van den Hoff, J. M.T. de Bakker, et al.
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
J. Exp. Med., August 3, 2009; 206(8): 1787 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Lombardi, J. Dong, G. Rodriguez, A. Bell, T. K. Leung, R. J. Schwartz, J. T. Willerson, R. Brugada, and A. J. Marian
Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy
Circ. Res., May 8, 2009; 104(9): 1076 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al.
Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study.
J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sen-Chowdhry, P. Syrris, S. K. Prasad, S. E. Hughes, R. Merrifield, D. Ward, D. J. Pennell, and W. J. McKenna
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.
J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2175 - 2187.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Basso, F. Ronco, F. Marcus, A. Abudureheman, S. Rizzo, A. C. Frigo, B. Bauce, F. Maddalena, A. Nava, D. Corrado, et al.
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria
Eur. Heart J., November 2, 2008; 29(22): 2760 - 2771.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna
Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al.
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al.
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis
Eur. Heart J., June 1, 2007; 28(11): 1326 - 1333.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Sen-Chowdhry, P. Syrris, D. Ward, A. Asimaki, E. Sevdalis, and W. J. McKenna
Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression
Circulation, April 3, 2007; 115(13): 1710 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Syrris, D. Ward, A. Asimaki, A. Evans, S. Sen-Chowdhry, S. E. Hughes, and W. J. McKenna
Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease
Eur. Heart J., March 1, 2007; 28(5): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Vatta, F. Marcus, and J. A. Towbin
Arrhythmogenic right ventricular cardiomyopathy: a 'final common pathway' that defines clinical phenotype
Eur. Heart J., March 1, 2007; 28(5): 529 - 530.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sen-Chowdhry, S. K. Prasad, P. Syrris, R. Wage, D. Ward, R. Merrifield, G. C. Smith, D. N. Firmin, D. J. Pennell, and W. J. McKenna
Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2132 - 2140.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al.
Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2
Circulation, April 4, 2006; 113(13): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Pilichou, A. Nava, C. Basso, G. Beffagna, B. Bauce, A. Lorenzon, G. Frigo, A. Vettori, M. Valente, J. Towbin, et al.
Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy
Circulation, March 7, 2006; 113(9): 1171 - 1179.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Basso, G. Thiene, A. Nava, G. H. Fontaine, P. Fornes, S. Sen-Chowdhry, P. Syrris, W. J. McKenna, M. Norman, J. Mogensen, et al.
Letter Regarding Article by Norman et al, "Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy" * Response
Circulation, February 7, 2006; 113(5): e68 - e69.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna
Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies
Eur. Heart J., August 2, 2005; 26(16): 1582 - 1584.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.